Cancer Treatment Acronyms
- November 24, 2020
- 0
Chemotherapy drugs
combination using several
different medications
This section aims to provide a reference list of abbreviations and acronyms that are frequently used within oncology.
Send Request
Have a Question ?
Treatment Options provided is not limited to given list. We do not recommend any one treatment over another and only your Doctor can decide this.
To learn more, please choose a Treatment below.
- 7 + 3 (Cytarabine + Daunorubicin) for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Daunorubicin) plus Midostaurin for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Idarubicin)for Acute Myeloid Leukemia (AML)
- AAVD (Brentuximab vedotin, Doxorubicin, Vinblastine, Dacarbazine) for Hodgkin’s Lymphoma
- ABCP (Atezolizumab (Tecentriq) + Bevacizumab + Carboplatin + Paclitaxel) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Abemaciclib (Verzenio®) for Breast Cancer – metastatic
- Abemaciclib (Verzenio®) + Fulvestrant (Faslodex®) for Breast Cancer – metastatic
- Abiraterone (Zytiga®) + Prednisone for Prostate Cancer
- Abraxane® (Paclitaxel protein-bound particles) for Breast Cancer – metastatic
- ABVD (Doxorubicin + Bleomycin + Vinblastine + Dacarbazine) for Hodgkin’s Lymphoma
- AC (Adriamycin® + Cyclophosphamide) followed by THP (Taxol® + Herceptin® + Pertuzumab) for Breast Cancer – early stage
- Acalabrutinib (Calquence®) for Lymphoma, Mantle Cell
- Acalabrutinib (Calquence®) for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib (Calquence®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- Ado-trastuzumab emtansine (Kadcyla®) for Breast Cancer – metastatic
- Afatinib (Gilotrif®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- AIM (Adriamycin® + Ifosfamide + Mesna) for Sarcoma
- Alectinib (Alecensa®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Alpelisib (Piqray®) + Fulvestrant (Faslodex®)
- Anastrozole (Arimidex®) for Breast Cancer – metastatic
- Anastrozole (Arimidex®) for Breast Cancer – early stage
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) for Severe Aplastic Anemia (SAA)
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) + Eltrombopag (Promacta®) for Severe Aplastic Anemia (SAA)
- Apixaban (Eliquis®) for Blood Clots
- Aprepitant (Emend®) for Nausea and Vomiting
- (Tecentriq®) for Bladder Cancer”>Atezolizumab
- Atezolizumab (Tecentriq®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) for Acute Promyelocytic Leukemia (APL)
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) Consolidation for Acute Promyelocytic Leukemia (APL)
- Avatrombopag (Doptelet®) for Immune Thrombocytopenic Purpura (ITP)
- Avelumab (Bavencio®) for Merkel Cell Carcinoma (MCC)
- Axitinib (Inlyta®) for Renal Cell Carcinoma – Kidney Cancer
- Azacitidine (Vidaza®) for Myelodysplastic Syndromes (MDS)
- Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- BCG (Bacillus Calmette-Guérin, Theracys®, TICE®) for Bladder Cancer
- BEAM (Carmustine + Etoposide + Cytarabine + Melphalan) for Autologous Stem Cell Transplant (autoSCT)
- Bendamustine (Bendeka®) + Rituximab for Lymphoma, B-cell
- Bendamustine (Bendeka®) + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- Bendamustine (Bendeka®) + Rituximab for Lymphoma, Mantle Cell
- BEP (Bleomycin + Etoposide + Cisplatin) 5-Day for Testicular Cancer
- BEP (Bleomycin + Etoposide + Cisplatin) 3-Day for Testicular Cancer
- Bexarotene (Targretin®) for Lymphoma, T-Cell
- Bicalutamide (Casodex®) for Prostate Cancer
- Bisacodyl (Dulcolax®) for Constipation
- Blinatumomab (Blincyto®) for Acute Lymphoid Leukemia (ALL)
- Bosutinib (Bosulif®) for Chronic Myeloid Leukemia (CML)
- Brentuximab Vedotin (Adcetris®) for Hodgkin’s Lymphoma
- Brentuximab Vedotin (Adcetris®) for Lymphoma, T-Cell
- Brigatinib (Alunbrig®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- BV-CHP (Brentuximab Vedotin (Adcetris®) + Cyclophosphamide + Doxorubicin + Prednisone) for Lymphoma, T-Cell
- C10403 Consolidation for Acute Lymphoid Leukemia (ALL)
- C10403 Delayed Intensification for Acute Lymphoid Leukemia (ALL)
- C10403 Induction for Acute Lymphoid Leukemia (ALL)
- C10403 Interim Maintenance for Acute Lymphoid Leukemia (ALL)
- C10403 Maintenance for Acute Lymphoid Leukemia (ALL)
- Cabazitaxel (Jevtana®) + Prednisone for Prostate Cancer
- Cabozantinib (Cometriq®) for Thyroid Cancer
- Capecitabine (Xeloda®) for Breast Cancer – metastatic
- Capecitabine (Xeloda®) for Colon Cancer
- Capecitabine (Xeloda®) + Oxaliplatin for Colon Cancer
- Carboplatin + Abraxane® (Paclitaxel protein-bound particles) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Docetaxel (Taxotere®) for Ovarian Cancer
- Carboplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Etoposide (Carbo/Etop) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Carboplatin + Fluorouracil + Cetuximab (Erbitux®)for Head and Neck Cancer
- Carboplatin + Gemcitabine (Gemzar®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Ovarian Cancer
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Uterine/Endometrial Cancer
- Carboplatin + Pemetrexed (Alimta®) (Carbo/Pem) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carfilzomib (Kyprolis®) for Multiple Myeloma (MM)
- Ceritinib (Zykadia®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cetuximab (Erbitux®) for Head and Neck Cancer
- CHOP (Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, T-Cell
- Cisplatin (Platinol®) + Irinotecan (Camptosar®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Etoposide for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Fluorouracil (5-FU) + Cetuximab (Erbitux®) for Head and Neck Cancer
- Cisplatin + Gemcitabine for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Gemcitabine (Gemzar®) for Pancreatic Cancer
- Cisplatin + Paclitaxel (Taxol®) for Cervical Cancer
- Cisplatin + Paclitaxel (Taxol®) + Bevacizumab for Cervical Cancer
- Cisplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Vinblastine + Radiation for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Vinorelbine (Navelbine®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CLAG-M (Cladribine + Cytarabine + G-CSF + Mitoxantrone) for Acute Myeloid Leukemia (AML)
- CRD (Carfilzomib + Revlimid® + Dexamethasone) for Multiple Myeloma (MM)
- Crizotinib (Xalkori®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CyBorD (Cyclophosphamide + Bortezomib + Dexamethasone) for Multiple Myeloma (MM)
- DA-EPOCH-R (Etoposide + Prednisone + Vincristine + Cyclophosphamide + Doxorubicin + Rituximab) for Lymphoma, B-cell
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Melanoma
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Daratumumab (Darzalex®) for Multiple Myeloma (MM)
- Dasatinib (Sprycel®) for Chronic Myeloid Leukemia (CML)
- Dasatinib (Sprycel®) for Acute Lymphoid Leukemia (ALL)
- Daunorubicin and cytarabine liposome (Vyxeos®) for Acute Myeloid Leukemia (AML)
- Decitabine (Dacogen®) for Myelodysplastic Syndromes (MDS)
- Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Dexamethasone (Decadron®) for Immune Thrombocytopenic Purpura (ITP)
- Dexamethasone (Decadron®) for Nausea and Vomiting
- Diphenoxylate and atropine (Lomotil®) for Diarrhea
- Docetaxel (Taxotere®) + Ramucirumab (Cyramza®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Docetaxel (Taxotere®) + Prednisone for Prostate Cancer
- Dose Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) followed by TH (Taxol® + Herceptin®) for Breast Cancer – early stage
- Dose Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) for Breast Cancer – early stage
- Dose-Dense MVAC (DD-Methotrexate + Vinblastine + Adriamycin + Cisplatin) for Bladder Cancer
- DPd (Daratumumab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- DRd (Daratumumab + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- Durvalumab (Imfinzi®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Durvalumab (Imfinzi®) for Bladder Cancer
- Duvelisib (Copiktra®) for Chronic Lymphocytic Leukemia (CLL)
- DVd (Daratumumab + Velcade® (bortezomib) + dexamethasone) for Multiple Myeloma (MM)
- Eltrombopag (Promacta®) for Immune Thrombocytopenic Purpura (ITP)
- Enasidenib (IDHIFA®) for Acute Myeloid Leukemia (AML)
- Encorafenib (Braftovi®) + Binimetinib (Mektovi®) for Melanoma
- Enoxaparin (Lovenox®) for Blood Clots
- Enzalutamide (Xtandi®) for Prostate Cancer
- ERd (Elotuzumab (Empliciti®) + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- Eribulin (Halaven®) for Breast Cancer – metastatic
- Erlotinib (Tarceva®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Everolimus (Afinitor®) for Renal Cell Carcinoma – Kidney Cancer
- fam-trastuzumab deruxtecan-nxki (Enhertu®) for Breast Cancer – metastatic
- FCR (Fludarabine + Cyclophosphamide + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Fentanyl (Duragesic®) for Pain
- Filgrastim (Neupogen®, Zarxio®, Nivestym®) for Neutropenic Fever
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Myeloid Leukemia (AML)
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Lymphoid Leukemia (ALL)
- FOLFIRI (Folinic acid + Fluorouracil + Irinotecan) for Colon Cancer
- FOLFIRI + Bevacizumab for Colon Cancer
- FOLFIRI + Cetuximab (Erbitux®) for Colon Cancer
- FOLFIRI + Panitumumab (Vectibix®) for Colon Cancer
- FOLFIRINOX (Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin) for Pancreatic Cancer
- FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) for Colon Cancer
- FOLFOX + Bevacizumab for Colon Cancer
- FOLFOX + Cetuximab (Erbitux®) for Colon Cancer
- FOLFOX + Panitumumab (Vectibix®) for Colon Cancer
- Fosaprepitant (Emend®) for Nausea and Vomiting
- Fostamatinib (Tavalisse®) for Immune Thrombocytopenic Purpura (ITP)
- Fulvestrant (Faslodex®) for Breast Cancer – metastatic
- Gemcitabine (Gemzar®) for Pancreatic Cancer
- Gemcitabine (Gemzar®) + Cisplatin for Bladder Cancer
- Gemcitabine + Abraxane® for Pancreatic Cancer
- Gemcitabine + Capecitabine (Xeloda®) for Pancreatic Cancer
- Gilteritinib (Xospata®) for Acute Myeloid Leukemia (AML)”> for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) + Midostaurin (Rydapt®) for Acute Myeloid Leukemia (AML)
- Hydroxyurea (Hydrea®, Droxia®) for Polycythemia Vera
- HyperCVAD (Part A) for Acute Lymphoid Leukemia (ALL)
- HyperCVAD (Part B) for Acute Lymphoid Leukemia (ALL)
- IBR (Ibrutinib + Bendamustine + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Ibrutinib (Imbruvica®) for Chronic Lymphocytic Leukemia (CLL)
- Ibrutinib (Imbruvica®) for Lymphoma, Mantle Cell
- Idelalisib (Zydelig®) + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- Imatinib (Gleevec®) for Chronic Myeloid Leukemia (CML)
- Imatinib (Gleevec®) for Gastrointestinal Stromal Tumor (GIST)
- Immune Globulin (IVIG, IV IgG) for Immune Thrombocytopenic Purpura (ITP)
- Inotuzumab Ozogamicin (Besponsa®) for Acute Lymphoid Leukemia (ALL)
- Intraperitoneal (IP) Cisplatin + IP Paclitaxel + Intravenous (IV) Paclitaxel for Ovarian Cancer
- IRd (Ixazomib + Revlimid® (lenalidomide) + dexamethasone) for Multiple Myeloma (MM)
- Isa-Pd (Isatuximab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- Lactulose for Constipation
- Lapatinib (Tykerb®) + Capecitabine (Xeloda®) for Breast Cancer – metastatic
- Lenalidomide (Revlimid®) for Myelodysplastic Syndromes (MDS)
- Letrozole (Femara®) for Breast Cancer – early stage
- Letrozole (Femara®) for Breast Cancer – metastatic
- Leuprolide acetate (Lupron Depot®, Eligard®) for Prostate Cancer
- Liposomal Doxorubicin (Doxil®) + Carboplatin for Ovarian Cancer
- Liposomal Vincristine (Marqibo®) for Acute Lymphoid Leukemia (ALL)
- Loperamide (Imodium®) for Diarrhea
- Lorazepam (Ativan®) for Nausea and Vomiting
- Low-dose Cytarabine (LDAC) for Acute Myeloid Leukemia (AML)
- Luspatercept (Reblozyl®) for Myelodysplastic Syndromes (MDS)
- Magnesium Citrate for Constipation
- Melphalan (Evomela®, Alkeran®) for Autologous Stem Cell Transplant (autoSCT)
- Metoclopramide (Reglan®) for Nausea and Vomiting
- Midostaurin (Rydapt®) for Systemic Mastocytosis
- Morphine (MSIR, MS Contin®, Kadian®, Arymo® ER, MorphaBond ER®) for Pain
- Nelarabine (Arranon®) for Acute Lymphoid Leukemia (ALL)
- Neratinib (Nerlynx®) for Breast Cancer – early stage
- Nilotinib (Tasigna®) for Chronic Myeloid Leukemia (CML)
- Niraparib (Zejula®) for Ovarian Cancer
- Nivolumab (Opdivo®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Nivolumab (Opdivo®) for Melanoma
- Nivolumab (Opdivo®) for Head and Neck Cancer
- Nivolumab (Opdivo®) for Bladder Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Melanoma
- Nivolumab (Opdivo®) for Hodgkin’s Lymphoma
- Olaparib (Lynparza®) for Ovarian Cancer
- Olaparib (Lynparza®) for Breast Cancer – metastatic
- Olaparib (Lynparza®) for Pancreatic Cancer
- Olaratumab (Lartruvo®) + Doxorubicin for Sarcoma
- Omacetaxine (Synribo®) for Chronic Myeloid Leukemia (CML)
- Ondansetron (Zofran®, Zofran ODT®) for Nausea and Vomiting
- Osimertinib (Tagrisso®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Oxycodone (Roxicodone®, Percocet®, OxyContin®, Oxaydo®, Xtampza®) for Pain
Available 24/7
Experiencing
symotoms that
concern you
- Paclitaxel (Taxol®) for Breast Cancer – early stage
- Palbociclib (Ibrance®) + Fulvestrant (Faslodex®) for Breast Cancer – metastatic
- Palbociclib (Ibrance®) + Letrozole (Femara®) for Breast Cancer – metastatic
- Palonosetron (Aloxi®) for Nausea and Vomiting
- Pazopanib (Votrient®) for Renal Cell Carcinoma – Kidney Cancer
- PBD (Panobinostat + Bortezomib + Dexamethasone) for Multiple Myeloma (MM)
- Pegfilgrastim (Neulasta®, Neulasta OnPro®, Udenyca®, Fulphila®, Ziextenzo®) for Neutropenic Fever
- Peginterferon alfa-2a (Pegasys®) for Polycythemia Vera
- Pembrolizumab (Keytruda®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) for Melanoma
- Pembrolizumab (Keytruda®) for Bladder Cancer
- Pembrolizumab (Keytruda®) + Carboplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Polyethylene Glycol (MiraLAX®) for Constipation
- Pomalidomide (Pomalyst®) for Multiple Myeloma (MM)
- POMP (6-Mercaptopurine + Vincristine + Methotrexate + Prednisone) for Acute Lymphoid Leukemia (ALL)
- Ponatinib (Iclusig®) for Chronic Myeloid Leukemia (CML)
- Ponatinib (Iclusig®) for Acute Lymphoid Leukemia (ALL)
- Prednisone for Immune Thrombocytopenic Purpura (ITP)
- Prochlorperazine (Compazine®) for Nausea and Vomiting
- Promethazine (Phenergan®) for Nausea and Vomiting
- Ramucirumab (Cyramza®) for Stomach Cancer
- R-CHOP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, B-cell
- Regorafenib (Stivarga®) for Colon Cancer
- Ribociclib (Kisqali®) + Fulvestrant (Faslodex®) for Breast Cancer – metastatic
- Ribociclib (Kisqali®) + Letrozole (Femara®) for Breast Cancer – metastatic
- RICE (Rituximab + Ifosfamide + Carboplatin + Etoposide) for Lymphoma, B-cell
- Rituximab (Rituxan®, Truxima®, Ruxience®) for Immune Thrombocytopenic Purpura (ITP)
- Rituximab + High Dose Methotrexate for Lymphoma, Primary CNS (PCNSL)
- Rituximab + Hyaluronidase (Rituxan Hycela®) for Lymphoma, B-cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, Mantle Cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, B-cell
- Rivaroxaban (Xarelto®) for Blood Clots
- Rolapitant (Varubi®) for Nausea and Vomiting
- Romidepsin (Istodax®) for Lymphoma, T-Cell
- Romiplostim (Nplate®) for Immune Thrombocytopenic Purpura (ITP)
- Rucaparib (Rubraca®) for Ovarian Cancer
- Ruxolitinib (Jakafi®) for Myelofibrosis
- Ruxolitinib (Jakafi®) for Polycythemia Vera
- RVd (Revlimid® + Velcade® + dexamethasone) for Multiple Myeloma (MM)
- Sacituzumab Govitecan (Trodelvy®) for Breast Cancer – metastatic
- Senna + Docusate (Senokot-S®, Senna-S®) for Constipation
- Sipuleucel-t (Provenge®) for Prostate Cancer
- Sorafenib (Nexavar®) for Renal Cell Carcinoma – Kidney Cancer
- Sunitinib (Sutent®) for Renal Cell Carcinoma – Kidney Cancer
- Tamoxifen for Breast Cancer – early stage
- Tamoxifen (Nolvadex®) for Breast Cancer – metastatic
- TC (Docetaxel + Cyclophosphamide) for Breast Cancer – early stage
- TCHP (Taxotere® + Carboplatin + Herceptin® + Perjeta®) for Breast Cancer – early stage
- Temozolomide (Temodar®) + Radiation for Brain Cancer
- for Renal Cell Carcinoma – Kidney Cancer”>Temsirolimus (Torisel®)
- THP (Taxotere® + Herceptin® + Perjeta®) for Breast Cancer – metastatic
- Tisagenlecleucel (Kymriah®) CAR T-Cells for Acute Lymphoid Leukemia (ALL)
- Topotecan (Hycamtin®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Topotecan + Paclitaxel + Bevacizumab for Cervical Cancer
- Trabectedin (Yondelis®) for Sarcoma
- Trifluridine and Tipiracil (Lonsurf®) for Colon Cancer
- Vemurafenib (Zelboraf®) + Cobimetinib (Cotellic®) for Melanoma
- Venetoclax (Venclexta®) + Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta®) + Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta) for Chronic Lymphocytic Leukemia (CLL)
- Venetoclax (Venclexta®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- VIP (Etoposide + Ifosfamide + Cisplatin) for Testicular Cancer
- VTd (Velcade® + Thalidomide + dexamethasone) for Multiple Myeloma (MM)
While taking medication, tell your doctor if you experience:
- An allergic reaction such as rash or hives
- A rash, swelling, bruising, or other reaction at the injection site
- New or worsening restless legs syndrome
Call your doctor for medical advice about side effects.
Please see full Prescribing Information for additional Important Safety Information.
